Related Experiment Video
Updated: May 10, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Data based medicine and clinical judgement
David Healy1, Derelie Mangin, David Antonuccio
1Department of Psychiatry, Cardiff University, Cardiff, UK. David.Healy54@googlemail.com
Randomized controlled trials (RCTs) can be misleading due to issues like unpublished data and hidden harms. This article explores how RCT outcomes can be compromised, leading to potentially incorrect conclusions about drug effectiveness.
Area of Science:
- Medical research methodology
- Clinical trial analysis
- Evidence-based medicine
Background:
- Randomized controlled trials (RCTs) are foundational in assessing drug efficacy.
- Concerns exist regarding the integrity and interpretation of RCT evidence.
- Issues include non-publication, data access limitations, ghostwriting, and data manipulation.
Purpose of the Study:
- To critically evaluate the limitations of RCTs in medical research.
- To highlight instances where RCTs may yield misleading results.
- To discuss the impact of these limitations on medical practice and patient care.
Main Methods:
- Literature review and critical analysis of existing research on RCTs.
- Examination of specific examples where RCT outcomes were potentially compromised.
- Discussion of methodological and ethical challenges in clinical trial reporting.
Main Results:
- RCTs are susceptible to biases from non-publication, restricted data access, and ghostwriting.
- When drugs and illnesses share similar effects, RCT outcomes can be profoundly misleading.
- Strategies to obscure trial data and patient harms can distort findings.
Conclusions:
- The reliability of RCTs is threatened by inherent biases and reporting issues.
- Over-reliance on potentially flawed RCT data can compromise medical care.
- Further scrutiny and transparency are needed in clinical trial conduct and reporting.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Documentation of Nursing Diagnosis
In some settings, data-driven computerized decision support systems are in place, allowing for more accurate nursing diagnoses. The database within one of these systems includes diagnostic labels defining characteristics, activities, and indicators for nursing. A nurse enters assessment...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Data Collection I
